Many high-risk Americans don't get hepatitis B vaccine
Although there is an effective vaccine for hepatitis B and public health officials have a strong sense of who is at highest risk for the infectious liver disease, tens of thousands of people in the United States contract the virus every year. According to a new study by researchers at Brown University, missed opportunities to administer the vaccine continue to be a reason why infections persist....
Source: PhysOrg - Thursday, 19 January
Related articles:
- Less than a few days ago
- 2Vote! Swine Flu Vaccine Yields Clues to Universal Flu Vaccine
Yahoo Science News - 4 days ago
- Older News
- 8Vote! Poll: Half of Americans call Facebook a fad
PhysOrg - Tuesday, 15 May
- 3Vote! Hepatitis C a latent legacy of baby boomers' youth
LabSpaces - Wednesday, 2 May
- 2Vote! Shingles vaccine is safe, according to new study
- 3Vote! Giving preventive drug to men at high risk for HIV would be cost-effective
- 2Vote! From herd immunity and complacency to group panic: How vaccine scares unfold
- 4Vote! Possible clues found to why HIV vaccine showed modest protection
- 2Vote! Scientists find promising vaccine targets on hepatitis C virus
- 4Vote! Cervical disease sufferers could benefit from HPV vaccine
- 4Vote! Sub-Saharan Africans join forces for TB vaccine research
SciDev.Net - Monday, 26 March - 6Vote! Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
- 3Vote! 'Kissing Bugs' May Suck Surprising Amount of American Blood
- 5Vote! As tides rise, flood risk grows higher
Futurity.org - Monday, 19 March
- 2Vote! Millions of Americans at risk of flooding as sea levels rise
- 2Vote! 4 Million Americans Threatened by Rising Seas
- 6Vote! Arctic evolution leads to salmonella vaccine
- 7Vote! Study: No significant rise in seizure risk from common kids' vaccine
- 7Vote! Study says overweight Americans may risk kidney damage when attempting weight loss
- 5Vote! Hepatitis C deaths up, baby boomers most at risk
- 9Vote! Benefits of hepatitis C treatment outweigh costs for patients with advanced disease
